Subscription info for Chinese customers
We have a dedicated website for our Chinese customers. Please go to naturechina.com to subscribe to this journal.
Get time limited or full article access on ReadCube.
All prices are NET prices.
Diamantopoulou, Z. et al. Nature https://doi.org/10.1038/s41586-022-04875-y (2022).
Taftaf, R. et al. Nature Commun. 12, 4867 (2021).
Rupp, B., Ball, H., Wuchu, F., Nagrath, D. & Nagrath, S. Trends Pharmacol. Sci. 43, 378–391 (2022).
Poudineh, M., Sargent, E. H., Pantel, K. & Kelley, S. O. Nature Biomed. Eng. 2, 72–84 (2018).
Szczerba, B. M. et al. Nature 566, 553–557 (2019).
Bishehsari, F., Voigt, R. M. & Keshavarzian, A. Nature Rev. Endocrinol. 16, 731–739 (2020).
Masri, S. & Sassone-Corsi, P. Nature Med. 24, 1795–1803 (2018).
Giuliano, M. et al. Cancer Res. 78, 845–852 (2018).
Keller, L. & Pantel, K. Nature Rev. Cancer 19, 553–567 (2019).
Kim, T. H. et al. Nature Commun. 10, 1478 (2019).
S.N. is one of the named inventors on a patent for Microfluidic Labyrinth Technology granted to the University of Michigan. This IP is licensed to the company Labyrinth Biotech. S.N. is the co-founder with equity interests and a scientific advisory board member for Labyrinth Biotech.